Brief: Lee's Pharmaceutical Holdings Says Qtrly Profit Attributable HK$42.1 Mln
28/11/2019 10:32
Nov 28 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* LEE'S PHARMACEUTICAL HOLDINGS LTD - QTRLY PROFIT
ATTRIBUTABLE
HK$42.1 MILLION VERSUS HK$71.7 MILLION
* LEE'S PHARMACEUTICAL HOLDINGS LTD - QTRLY REVENUE HK$306.3
MILLION VERSUS HK$299.2 MILLION
* LEE'S PHARMACEUTICAL HOLDINGS ANNOUNCES INTERIM DIVIDEND
FOR SIX
MONTHS ENDED 30 JUNE 2019 OF HK$0.018 PER SHARE
* LEE'S PHARMACEUTICAL HOLDINGS LTD - BOARD DOES NOT
RECOMMEND
PAYMENT OF OTHER INTERIM DIVIDEND FOR NINE MONTHS ENDED 30 SEPT
2019
Source text http://bit.ly/35IB46A
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals